Can I still interact with my study subjects?

Last update: 4.14.2020

As of April 14, 2020, all face-to-face study visits must be temporarily halted until at least June 30, 2020 to align with other campus guidance. Study teams have the option to postpone visits or submit a change of protocol to conduct visits remotely (see below). This applies to ALL human subjects research conducted by UW-Madison researchers, regardless of reviewing IRB. Human subjects research that is conducted online or using other remote data collection methodologies (email, mail, phone, etc.) may continue.

Exceptions to this hiatus are therapeutic studies involving drugs or devices, or other research activities that are critical to the health/safety of patients or study participants. These studies may continue using face-to-face interactions. The determination of whether a research visit is essential to the health/safety of a participant is determined by the principal investigator, the participant, and the participant's care provider, and should be informed by current public health guidance regarding the COVID-19 outbreak.

Even for therapeutic studies, we recommend moving toward remote data collection methods to the extent possible (for instance, telephone or electronic methods for screening or follow-up).

Keywords:coronavirus, COVID-19, subject interaction, face-to-face study visits   Doc ID:98900
Owner:Monica E.Group:Health Sciences IRBs
Created:2020-03-16 11:34 CSTUpdated:2020-04-14 09:58 CST
Sites:Health Sciences IRBs
Feedback:  0   0